Clinical use of selective estrogen receptor modulators

被引：7

作者：

Delmas, PD

机构：

[1] INSERM, Res Unit 403, F-69008 Lyon, France

[2] Univ Lyon 1, F-69365 Lyon, France

来源：

BONE | 1999年 / 25卷 / 01期

关键词：

osteoporosis; breast cancer; estrogen; lipids;

D O I：

10.1016/S8756-3282(99)00107-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：115 / 118

页数：4

共 30 条

[1] BJARNASON K, 1997, J BONE MINER RES S, V12, P346
[2] Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits
Bjarnason, NH
Haarbo, J
Byrjalsen, I
Kauffman, RF
Christiansen, C
[J]. CIRCULATION, 1997, 96 (06) : 1964 - 1969
[3] Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, AM
Pike, ACW
Dauter, Z
Hubbard, RE
Bonn, T
Engstrom, O
Ohman, L
Greene, GL
Gustafsson, JA
Carlquist, M
[J]. NATURE, 1997, 389 (6652) : 753 - 758
[4] Chang J, 1996, ANN ONCOL, V7, P671
[5] Clarke M, 1998, LANCET, V351, P1451
[6] Gonadal hormone substitutes: Effects on the cardiovascular system
Clarkson, TB
Cline, JM
Williams, JK
Anthony, MS
[J]. OSTEOPOROSIS INTERNATIONAL, 1997, 7 (Suppl 1) : 43 - 51
[7] Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
Clarkson, TB
Anthony, MS
Jerome, CP
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 721 - 726
[8] CUMMINGS SR, 1998, P AN M AM SOC CLIN, V17, P2
[9] Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
Delmas, PD
Bjarnason, NH
Mitlak, BH
Ravoux, AC
Shah, AS
Huster, WJ
Draper, M
Christiansen, C
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) : 1641 - 1647
[10] Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study
Delmas, PD
Balena, R
Confravreux, E
Hardouin, C
Hardy, P
Bremond, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 955 - 962

← 1 2 3 →